Angiogenic potency of bone marrow stromal cells improved byex vivo hypoxia prestimulation

Abstract

To study the angiogenic potency of hypoxia-prestimulated bone marrow stromal cells (BMSCs) when transplanted into acute myocardial infarction models of rats. BMSCs were cultured under hypoxia condition for 24 h. Their expression of VEGF was investigated. The rat acute myocardial infarction models were made by coronary artery ligation and divided into 3 groups at random. In normoxia group, twice-passaged BMSCs were labeled with Bromodeoxyuridine (BrdU) and then implanted into the infarction regions and ischemic border of the recipients in 4 weeks. The rats in hypoxia group were implanted with hypoxia-prestimulated BMSCs. In control group, the model rats received only DMEM medium injection. Six—weeks after AMI, the infarction regions were examined to identify the angiogenesis and the expression of the VEGF. Our results showed that viable cells labeled with BrdU could be identified in the host hearts. The infarction regions in normoxia and hypoxia groups had a greater capillary density and increased VEGF expression than the regions in control group. The capillary density and VEGF expression in hypoxia group were higher than in normoxia group. It is concluded that the enhanced expression of VEGF in BMSCs could be induced byex vivo hypoxia stimulation. BMSCs implantation promoted the angiogenesis in myocardial infarction tissue via supplying exogenic VEGF. Angiogenic potency of bone marrow stromal cells was improved byex vivo hypoxia prestimulation though the enhanced VEGF expression.

Keywords

stromal cells / bone marrow / myocardial infarction / vascular endothelial growth factor / angiogenesis

References

[1] DarwinJ P. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 1999, 276(4): 71-71

[2] TomitaS, OrlicDonald, RichardD, et al. . Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg, 2002, 123(6): 1132-1132

[3] CarmelietP. Mechanism of angiogenesis and arteriogenesis. Nat Med, 2000, 6(3): 389-389

[4] HendelR C, HennyT D, Rocha-SighK, et al. . Effect of intracoronary reconbinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-depended effect. Circ, 2000, 101(1): 118-118

[5] MajkaM, Janowsk-WieczorekA, RatajczakJ, et al. . Numerous growth factors, cytokines, and chemokines are secreted by human CD34⁺ cell, myeloblasts, erythroblasts and megakaryoblasts, and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood, 2001, 97: 30752-30752

[6] HashimotoE, OgitaT, NakackaT, et al. . Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol, 1994, 276: H1948-H1948

[7] MaruyamaK, MoriY, MurasawaS, et al. . Interleukin-1 upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases. J Mol Cell Cardiol, 1999, 31: 607-607